| Parecoxib. Pharmacia corp. | |
| | |
MedLine Citation:
|
PMID: 15973593 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Pharmacia (formerly Monsanto) is developing parecoxib, an injectable COX-2 inhibitor, for the management of post-surgical acute pain [287279], [313957]. By January 1999, the compound was in phase III trials for this indication [312280]. In October 2000, Pharmacia submitted an NDA for parecoxib sodium for the management of acute pain to the FDA. The company anticipated a 12-month review of the NDA [387654] but received a 'not approvable' letter in July 2001, indicating there were deficiencies in the filing; at this time, Pharmacia anticipated refiling before the end of 2002 [415668]. Under a license agreement with Pharmacia Corp, parecoxib (designated YM-177) is being developed in Japan by Yamanouchi [392030]. Prior to the FDA ruling, in June 2000, the company anticipated that the compound would be launched by 2001 [370466]. In March 2000, Merrill Lynch predicted that parecoxib would be filed in the third quarter of 2000 [361969], [382577]. By May 2001, the analysts revised their predictions to launch in 2002 [411811]. |
| | |
Authors:
|
A W Gotta |
Related Documents
:
|
16269163 - Envenoming by the viperid snake eristicophis macmahonii. 16006183 - Genomic medicine: bringing biomarkers to clinical medicine. 8506903 - The arts of war and medicine: a study in symbiosis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 4 ISSN: 1369-7056 ISO Abbreviation: IDrugs Publication Date: 2001 Aug |
Date Detail:
|
Created Date: 2005-06-23 Completed Date: 2005-07-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 939-44 Citation Subset: - |
Affiliation:
|
Professor Emeritus of Anesthesiology, State University of New York, Downstate Medical Center, New York, NY, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: CBP-1011. InKine Pharmaceutical Co.
Next Document: Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI ...